CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides

Stock Information for CDT Equity Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About CDT Equity Inc.

CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
CDT Equity Inc. Announces Reverse Stock Split
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.